BF Biosciences inks deal with Lucky Core

MG News | September 04, 2024 at 10:30 AM GMT+05:00

0:00

September 04, 2024 (MLN): BF Biosciences Limited (BFBL)has entered into a contract manufacturing and supply agreement with Lucky Core Industries Limited (LCI) for the products "Esopase IV 40 mg" & "Etipro IV 40 mg", the company's filing on PSX revealed.

BFBL is a subsidiary of Ferozsons Laboratories Limited (PSX: FEROZ).

In August, BF Biosciences successfully launched human insulin under the brand name "Ferulin".

BF Biosciences was established exclusively for the manufacture of biologicals and it is the first and only company in Pakistan currently to have a biotech manufacturing facility.

Copyright Mettis Link News

Related News

Weekly Market Roundup

MLCF profit doubles in Q3FY25

Pakistani Shariah-Compliant Insurer plans $3.9m IPO

Name	Price/Vol	%Chg/NChg
KSE100	163,806.22 500.44M	-0.39% -638.50
ALLSHR	99,845.79 1,977.49M	-0.42% -417.42
KSE30	50,123.85 153.24M	-0.68% -343.31
KMI30	238,530.50 71.49M	-0.36% -850.63
KMIALLSHR	65,898.10 543.80M	-0.37% -245.35
BKTi	46,380.96 92.15M	-0.49% -229.01
OGTi	31,857.40 12.33M	-1.20% -387.93

Symbol	Bid/Ask	High/Low

Name	Last	High/Low	Chg/%Chg
BITCOIN FUTURES	108,300.00	109,605.00 107,690.00	1625.00 1.52%
BRENT CRUDE	61.06	61.55 60.99	-0.23 -0.38%
RICHARDS BAY COAL MONTHLY	80.50	0.00 0.00	-1.00 -1.23%
ROTTERDAM COAL MONTHLY	93.20	93.50 93.20	0.05 0.05%
USD RBD PALM OLEIN	1,085.00	1,085.00 1,085.00	0.00 0.00%
CRUDE OIL - WTI	56.95	57.43 56.87	-0.20 -0.35%
SUGAR #11 WORLD	15.53	15.88 15.45	-0.27 -1.71%